What is the typical dosing regimen for NPH (Neutral Protamine Hagedorn) intermediate-acting insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dosing Regimen

The typical dosing regimen for NPH (Neutral Protamine Hagedorn) insulin is to start with 10 units per day or 0.1-0.2 units/kg per day, with subsequent adjustments of 2 units every 3 days based on fasting blood glucose monitoring until target range is achieved. 1, 2

Initial Dosing

  • Start with 10 units per day OR 0.1-0.2 units/kg per day 1
  • For insulin-naive patients, consider starting at the lower end of the range (0.1-0.2 units/kg/day) 2
  • Total daily insulin requirement typically ranges from 0.4-1.0 units/kg/day for most patients 2

Administration Schedule

NPH insulin can be administered in different schedules depending on glycemic control needs:

Once-daily regimen:

  • Typically administered at bedtime
  • Useful when initiating insulin in type 2 diabetes patients previously on oral agents 1

Twice-daily regimen:

  • Morning and bedtime dosing
  • When converting from once-daily to twice-daily NPH:
    • Total dose = 80% of current bedtime NPH dose
    • 2/3 given in the morning, 1/3 given at bedtime 1
  • More effective for controlling glucose throughout the day 1

Special situations:

  • For patients on glucocorticoid therapy: NPH insulin is particularly useful as its peak action (4-6 hours) aligns with the peak glucose-raising effect of intermediate-acting steroids like prednisone 1
  • For enteral/parenteral nutrition: NPH can be given every 8-12 hours to cover nutritional requirements 1

Dose Titration

  • Set fasting plasma glucose (FPG) target (typically 90-150 mg/dL) 1, 2
  • Increase dose by 2 units every 3 days until FPG target is reached without hypoglycemia 1, 2
  • If hypoglycemia occurs, determine the cause; if no clear reason, lower dose by 10-20% 1
  • For older adults, consider less stringent targets (90-150 mg/dL) to reduce hypoglycemia risk 2

Combination Therapy

  • NPH can be used alone or in combination with:
    • Oral antidiabetic agents (particularly metformin) 3, 4
    • Prandial insulin (regular or rapid-acting analogs) 1
  • When adding prandial insulin to NPH:
    • Start with 4 units per day or 10% of basal dose 1
    • Consider reducing NPH dose by 10% if A1C <8% 1
    • Increase prandial dose by 1-2 units or 10-15% twice weekly 1

Monitoring

  • Check blood glucose before breakfast daily during titration 2
  • Additional checks before lunch and dinner may help assess 24-hour control 2
  • Monitor for hypoglycemia, especially during the first 12 weeks of therapy 4

Clinical Considerations

  • NPH has an intermediate duration of action with onset at approximately 30 minutes, peak effect between 2-12 hours, and duration up to 24 hours 5
  • NPH insulin must be thoroughly mixed before administration by gently rotating the vial or pen (do not shake) 5
  • Compared to long-acting insulin analogs (e.g., glargine), NPH has:
    • Higher risk of nocturnal hypoglycemia 6
    • Less consistent 24-hour coverage 6
    • More pronounced peak effect 6

Common Pitfalls and Caveats

  1. Inadequate mixing: NPH is a suspension that settles; failure to mix thoroughly can lead to dosing errors 5
  2. Fixed timing: NPH should be administered at consistent times each day to maintain stable glucose levels 5
  3. Nocturnal hypoglycemia: Due to its peak action, bedtime NPH carries higher risk of overnight hypoglycemia compared to long-acting analogs 6
  4. Storage issues: NPH should be stored in a refrigerator (36-46°F) but not frozen; in-use vials can be kept at room temperature (<86°F) for limited time 5
  5. Dose adjustments: Many patients fail to achieve glycemic targets because of insufficient dose titration; regular monitoring and adjustment are essential 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.